Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Archives of Dermatology
|
June 22, 2005
0.1% tacrolimus ointment for the treatment of intertrigo
M Shane Chapman, Joanne M Brown, Gregory J Linowski
Journal of the American Academy of Dermatology
|
September 16, 2014
Bullous Lyme disease
Jeffrey B Tiger, Marshall A Guill, M Shane Chapman
Cutis
|
May 11, 2016
Intralymphatic histiocytosis associated with an orthopedic metal implant
Kassie A Haitz, M Shane Chapman, Gregory D Seidel
Dermatitis : Contact, Atopic, Occupational, Drug
|
January 28, 2022
Expert Opinion on Patch Testing While Receiving Immunomodulatory Therapy Results of an International Survey Study
Keegan O'Hern, M Shane Chapman, Kathryn A Zug, et al.
Journal of the American Academy of Dermatology
|
November 4, 2004
Genital ulcers caused by Epstein-Barr virus
Sola X Cheng, M Shane Chapman, Lynette J Margesson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 23, 2017
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review
Andrew J Park, Joan Paul, M Shane Chapman, et al.
Cutis
|
November 24, 2006
Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports
Gregory L Wells, Joanne Brown, Wendy D Manganiello, et al.
JAAD Case Reports
|
May 5, 2021
Novel heterozygous <i>COL7A1</i> mutation in a patient with de-novo dominant dystrophic epidermolysis bullosa pruriginosa
Tasya Rakasiwi, Shu Ting Liang, Brian J Simmons, et al.
Journal of the American Academy of Dermatology
|
April 25, 2006
Treatment of verrucous carcinoma with topical imiquimod
Peter C Schalock, Rachel I Kornik, Richard D Baughman, et al.
Journal of the American Academy of Dermatology
|
May 11, 2002
Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder
Wendy S Susser, Amanda G Heermans, M Shane Chapman, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Archives of Dermatology
|
June 22, 2005
0.1% tacrolimus ointment for the treatment of intertrigo
M Shane Chapman, Joanne M Brown, Gregory J Linowski
Journal of the American Academy of Dermatology
|
September 16, 2014
Bullous Lyme disease
Jeffrey B Tiger, Marshall A Guill, M Shane Chapman
Cutis
|
May 11, 2016
Intralymphatic histiocytosis associated with an orthopedic metal implant
Kassie A Haitz, M Shane Chapman, Gregory D Seidel
Dermatitis : Contact, Atopic, Occupational, Drug
|
January 28, 2022
Expert Opinion on Patch Testing While Receiving Immunomodulatory Therapy Results of an International Survey Study
Keegan O'Hern, M Shane Chapman, Kathryn A Zug, et al.
Journal of the American Academy of Dermatology
|
November 4, 2004
Genital ulcers caused by Epstein-Barr virus
Sola X Cheng, M Shane Chapman, Lynette J Margesson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
March 23, 2017
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review
Andrew J Park, Joan Paul, M Shane Chapman, et al.
Cutis
|
November 24, 2006
Tacrolimus ointment 0.1% for the treatment of peristomal skin disease: 3 case reports
Gregory L Wells, Joanne Brown, Wendy D Manganiello, et al.
JAAD Case Reports
|
May 5, 2021
Novel heterozygous <i>COL7A1</i> mutation in a patient with de-novo dominant dystrophic epidermolysis bullosa pruriginosa
Tasya Rakasiwi, Shu Ting Liang, Brian J Simmons, et al.
Journal of the American Academy of Dermatology
|
April 25, 2006
Treatment of verrucous carcinoma with topical imiquimod
Peter C Schalock, Rachel I Kornik, Richard D Baughman, et al.
Journal of the American Academy of Dermatology
|
May 11, 2002
Elephantiasic pretibial myxedema: a novel treatment for an uncommon disorder
Wendy S Susser, Amanda G Heermans, M Shane Chapman, et al.
Page
of 5